Influence of Branched Ligand Architectures on Nanoparticle Interactions with Lipid Bilayers DOI
Carlos A. Huang-Zhu, Reid C. Van Lehn

Nanoscale, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 27, 2024

We utilize coarse-grained molecular dynamics simulations and enhanced sampling methods to reveal the effect of ligand branching on thermodynamics nanoparticle adsorption lipid bilayers.

Язык: Английский

Recent advances on nanomaterials-based photothermal sensing systems DOI
Min Zhang,

Zhihua Xu,

Jiaqi Chen

и другие.

TrAC Trends in Analytical Chemistry, Год журнала: 2024, Номер 177, С. 117801 - 117801

Опубликована: Июнь 7, 2024

Язык: Английский

Процитировано

7

Comparative activity of dimethyl fumarate derivative IDMF in three models relevant to multiple sclerosis and psoriasis DOI Creative Commons

Yulin He,

Guiyi Gong, Geovani Quijas

и другие.

FEBS Open Bio, Год журнала: 2025, Номер unknown

Опубликована: Янв. 17, 2025

Dimethyl fumarate (DMF) is an anti‐inflammatory and immunoregulatory medication used to treat multiple sclerosis (MS) psoriasis. Its skin sensitization property precludes its topical use, which unfortunate for the treatment of Isosorbide di‐(methyl fumarate) (IDMF), a novel derivative DMF, was synthesized circumvent this adverse reaction unlock potential delivery, could be useful treating psoriasis in subpopulation psoriatic MS patients, as well general population. Here, we compared therapeutic non‐sensitizing with DMF version Diroximel three skin‐ neuroinflammation models: lck‐GFP zebrafish, activated BV‐2 murine microglia human T‐lymphocyte Jurkat cell line. The results provide comparative evaluation bioactivity these related chemical entities models relevant expose several advantages unique IDMF.

Язык: Английский

Процитировано

0

Novel Small-Molecule Treatment and Emerging Biological Therapy for Psoriasis DOI Creative Commons
Yuanyuan Li,

Yiheng Cheng,

Yuchen Cai

и другие.

Biomedicines, Год журнала: 2025, Номер 13(4), С. 781 - 781

Опубликована: Март 23, 2025

Psoriasis is an immune-related disorder that marked by abnormal thickening of the skin, rapid multiplication keratinocytes, and complex interactions between immune cells affected areas. Although psoriasis cannot currently be cured, drugs can alleviate symptoms regulating homeostasis preventing comorbidities. There are many types to treat psoriasis: small-molecule drugs, including corticosteroids; retinoids; vitamin D analogs; immunosuppressants, such as glucocorticoid ointment, tretinoin cream, methotrexate tablets, etc. Macromolecular biological Certolizumab, Secukinumab, Guselkumab, etc., include monoclonal antibodies target various inflammatory signaling pathways. Compared with traditional therapies offer better targeting lower systemic side effects, but their high costs invasive administration modes constrict widespread use. Spesolimab latest agent used interleukin-36 receptor (IL-36R) approved for market use, which significantly reduces risk general pustular (GPP) flare 84%. Additionally, there several agents interleukin-23/T helper 17 cell pathway have already entered Phase II III clinical trials. At present, first-line therapeutic strategy mild topical administration. Systemic therapy phototherapy preferred treating moderate severe types. However, current completely meet needs. More advanced drug delivery systems optimized effects bioavailability required. Nanocarriers emerging proteins, nucleic acids, cell-based therapies. In this review, we analyze status therapeutics discuss novel diverse well We also summarize effectiveness different strategies.

Язык: Английский

Процитировано

0

Scalable Drug-Mimicking Nanoplasmonic Therapy for Bradyarrhythmia in Cardiomyocytes DOI
Dongxin Xu,

Xuelian Lyu,

Haote Han

и другие.

Nano Letters, Год журнала: 2024, Номер 24(36), С. 11302 - 11310

Опубликована: Авг. 30, 2024

Bradyarrhythmia poses a serious threat to human health, with chronic progression causing heart failure and acute onset leading sudden death. In this study, we develop scalable drug-mimicking nanoplasmonic therapeutic strategy by introducing gold nanorod (Au NR) mediated near-infrared (NIR) photothermal effects. An integrated sensing regulation platform is established for in situ synchronized NIR laser electrophysiological property recording. The Au NR plasmonic enables the restoration of normal cardiomyocyte rhythm from bradyarrhythmia. By regulating aspect ratio concentration NRs, as well intensity time irradiation, precisely optimized effect explore effective strategies. Furthermore, mRNA sequencing revealed significant increase number differentially expressed genes (DEGs) involved activities cardiomyocytes following therapy. NR-mediated therapy, an efficient noninvasive approach bradyarrhythmia, holds profound implications cardiology research.

Язык: Английский

Процитировано

2

Self-assembled hollow CuS@AuNRs/PDA nanohybrids with synergistically enhanced photothermal efficiency DOI

Chiyin Zhang,

Panping Yang,

Jingguo Li

и другие.

Dalton Transactions, Год журнала: 2024, Номер 53(34), С. 14315 - 14324

Опубликована: Янв. 1, 2024

A NIR/pH dual-responsive hollow CuS@AuNRs/PDA nanocarrier with synergistically enhanced photothermal efficiency was prepared by electrostatic self-assembly method.

Язык: Английский

Процитировано

1

Indoleamine-2,3-dioxygenase (IDO) Mediates the Suppression of T Cells by IFN-γ Primed Mesenchymal Stromal Cells in the Treatment of Psoriasis-Like Inflammation DOI Creative Commons
Weidong Zhu, Chang Qi,

Chenxi Shi

и другие.

Frontiers in Bioscience-Landmark, Год журнала: 2024, Номер 29(12)

Опубликована: Дек. 5, 2024

Psoriasis is a chronic and incurable skin inflammation driven by an abnormal immune response. Our study aims to investigate the potential of interferon-γ (IFN-γ) primed mesenchymal stem cells (IMSCs) in targeting T attenuate psoriasis-like inflammation, elucidate underlying molecular mechanism involved. Mesenchymal (MSCs) were isolated from umbilical cord identified based on their surface markers. models established then treated with IMSCs. Flow cytometry analysis was used examine cell markers percentages. Indoleamine-2,3-dioxygenase (IDO) knocked down small interfering RNA (siRNA) examined western blot assay. The proliferative capacity assessed using water-soluble tetrazolium salt-1(WST-1). Additionally, immunohistochemical assay determine epidermal thickness. psoriasis area severity index (PASI) scores also assessed. We observed significant therapeutic efficacy IMSCs against mice. Treatment resulted notable reduction infiltration within psoriatic lesions. Furthermore, we demonstrated that mediated upregulation IDO through IFN-γ stimulation. In vitro, inhibited proliferation, vivo, eliminated when MSCs transfected siRNA. can treat suppressing suppression IDO.

Язык: Английский

Процитировано

0

Gold nanorods as biocompatible nano-agents for the enhanced photothermal therapy in skin disorders DOI Open Access
Yamei Gao,

Shaohu Huo,

Chao Chen

и другие.

Journal of Biomedical Research, Год журнала: 2024, Номер 38, С. 1 - 1

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

0

Influence of Branched Ligand Architectures on Nanoparticle Interactions with Lipid Bilayers DOI
Carlos A. Huang-Zhu, Reid C. Van Lehn

Nanoscale, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 27, 2024

We utilize coarse-grained molecular dynamics simulations and enhanced sampling methods to reveal the effect of ligand branching on thermodynamics nanoparticle adsorption lipid bilayers.

Язык: Английский

Процитировано

0